Renaissance Technologies’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-596
Closed -$3K 4186
2023
Q4
$3K Buy
+596
New +$3.96K ﹤0.01% 3677
2021
Q3
Sell
-958
Closed -$196K 3944
2021
Q2
$196K Sell
958
-567
-37% -$126K ﹤0.01% 3252
2021
Q1
$459K Sell
1,525
-242
-14% -$81.9K ﹤0.01% 2935
2020
Q4
$245K Sell
1,767
-564
-24% -$85.6K ﹤0.01% 3091
2020
Q3
$435K Buy
+2,331
New +$344K ﹤0.01% 2865
2020
Q1
Sell
-607
Closed -$100K 3900
2019
Q4
$100K Buy
607
+118
+24% +$37.5K ﹤0.01% 3326
2019
Q3
$236K Sell
489
-9
-2% -$7.14K ﹤0.01% 3098
2019
Q2
$463K Buy
498
+43
+9% +$41.1K ﹤0.01% 3022
2019
Q1
$498K Buy
455
+27
+6% +$29.1K ﹤0.01% 2921
2018
Q4
$341K Buy
428
+15
+4% +$18.3K ﹤0.01% 2990
2018
Q3
$570K Buy
413
+14
+4% +$19K ﹤0.01% 2813
2018
Q2
$541K Buy
399
+46
+13% +$72.9K ﹤0.01% 2809
2018
Q1
$661K Buy
353
+270
+325% +$457K ﹤0.01% 2821
2017
Q4
$141K Buy
83
+62
+295% +$168K ﹤0.01% 3186
2017
Q3
$65K Buy
+21
New +$59K ﹤0.01% 3114
2017
Q2
Sell
-4
Closed -$14K 3404
2017
Q1
$14K Buy
+4
New +$14.2K ﹤0.01% 3183
2014
Q3
Sell
-1
Closed -$49K 2991
2014
Q2
$49K Hold
1
﹤0.01% 2714
2014
Q1
$67K Hold
1
﹤0.01% 2740
2013
Q4
$85K Hold
1
﹤0.01% 2745
2013
Q3
$63K Hold
1
﹤0.01% 2730
2013
Q2
$90K Buy
+1
New +$96.7K ﹤0.01% 2642

Other funds holding YTEN

Renaissance Technologies's YTEN Position: Q1 2024 in Review

Renaissance Technologies sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q1 2024, closing a stake of 596 shares — an estimated $3K sold.

Renaissance Technologies first reported a position in YTEN in Q2 2013 and held it in 21 quarters. The position peaked at $661K in Q1 2018. 19 funds tracked by Wall St. Rank hold YTEN as of Q1 2024.

  • Renaissance Technologies reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Renaissance Technologies sold 596 Yield10 Bioscience, Inc. Common Stock shares in Q1 2024, an estimated $3K.
  • Renaissance Technologies first reported a position in Yield10 Bioscience, Inc. Common Stock in Q2 2013 and held it in 21 quarters.
  • Renaissance Technologies's Yield10 Bioscience, Inc. Common Stock position peaked at $661K in Q1 2018.
  • 19 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q1 2024.

Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.